Infantile free sialic acid storage disease
 | This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations. (March 2011) |
| Infantile free sialic acid storage disease | |
|---|---|
 | |
| This condition is inherited via an autosomal recessive manner |
Infantile free sialic acid storage disease (ISSD) is a lysosomal storage disease [1]Occurs when a sialic acid, is unable to be transported out of the lysosomal membrane and instead, accumulates in the tissue and free sialic acid is excreted in the urine. Mutations in the SLC17A5 (solute carrier family 17 (anion/sugar transporter), member 50) gene cause all forms of sialic acid storage disease. The SLC17A5 gene is located on the long (q) arm of chromosome 6 between positions 14 and 15. This gene provides instructions for producing a protein called sialin that is located mainly on the membranes of lysosomes, compartments in the cell that digest and recycle materials.[citation needed]
ISSD is the most severe form of the sialic acid storage diseases. Babies with this condition have severe developmental delay, weak muscle tone (hypotonia), and failure to gain weight and grow at the expected rate (failure to thrive). They may have unusual facial features that are often described as "coarse," seizures, bone malformations, enlarged liver and spleen (hepatosplenomegaly), and an enlarged heart (cardiomegaly).
ISSD is a rare autosomal recessive disorder and affects 1 in 528,000 live births worldwide.
Symptoms
Symptoms present by eight months of age and are marked by developmental delay followed by neurological complications such as seizures, involuntary eye movements, and ataxia, involuntary muscle movements and failure to gain weight and grow at the expected rate (failure to thrive). Babies with this condition also have and enlarged liver and spleen (hepatosplenomegaly) and enlarged heart (cardiomegaly).
Cause
![[icon]](/wiki/File:Wiki_letter_w_cropped.svg){kind=small} | This section is empty. You can help by adding to it. (July 2017) |
Diagnosis
A diagnosis can be made by measuring cultured tissue samples for increased levels of free sialic acid. Prenatal testing is also available for known carriers of this disorder.
Treatment
There is no treatment for ISSD. Treatment is limited to controlling the symptoms of this disorder such as administering anti-convulsant medication to control seizure episodes.
References
- ^ "OMIM Entry - # 269920 - INFANTILE SIALIC ACID STORAGE DISEASE; ISSD". omim.org. Retrieved 2017-05-27.